Kumarappan Chidambaram is an assistant professor in the Department of Pharmacology & Toxicology in the College of Pharmacy at King Khalid University, Saudi Arabia. His research focuses on the impacts of oxidative stress and reactive oxygen species (ROS) in metabolic syndromes, cancer, and other major inflammatory disorders, particularly in connection to their potential pathogenic implications. His research has focused on developing effective therapies for chronic illnesses, utilizing a combination of in vivo, in vitro, and computational models for the past 15 years. He is also interested in traditional herbal medicine drug discovery. He has published over 70 full-length papers in international scientific journals. He is an active member of ACCP, AALAS, and ISE. He was trained as a pharmacologist at the molecular and cellular levels, with special emphasis on the pathogenesis of inflammatory disorders and therapeutic development.